Effects of Inhibiting Early Inflammation in Kidney Transplant Patients

What is the purpose of this trial?

The objective of the study is to determine the efficacy of intravenous infliximab administered at the time of transplantation, prior to reperfusion, on 2-year kidney transplant survival and function.


Participation Guidelines

Ages: 18 years and older

Gender: Both


Icahn School of Medicine at Mount Sinai

Start Date: 10/19/2015

End Date: 08/01/2020

Last Updated: 02/22/2018

Study HIC#: 1507016169

Get Involved

For more information about this study, contact:
Ricarda Tomlin
+1 203-785-2073
ricarda.tomlin@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image

Investigators

Richard Nicholas Formica

Principal Investigator

Sub-Investigators